氯胺酮快速抗抑郁效应的神经生物学:影响与机遇
本文综述氯胺酮快速抗抑郁效应的发现历史与 putative 机制,基于临床前 findings 详述其分子与环路效应,并总结该工作对理解慢性应激病理及突触连接在抑郁症病理与治疗中作用的影响。
要点
- 氯胺酮快速抗抑郁效应推动重度抑郁症治疗认知转变并激发大量基础、转化与临床研究。
- 针对氯胺酮受体靶点的多项临床试验在过去十年未成功,需聚焦下游分子机制。
- 临床前 findings 支持突触连接及其脑网络效应在抑郁症病理与治疗中的角色。
核心结论
- 氯胺酮快速抗抑郁效应带来治疗认知转变并催生大量研究,但尚未转化为临床生物标志物或氯胺酮以外的新疗法。
- 针对氯胺酮受体靶点的多项临床试验在过去十年未成功,应聚焦下游分子机制及其对脑环路与网络的影响。
研究设计与样本
- 本文为综述,包含氯胺酮发现的历史注记,并基于临床前 findings 详述其分子与环路效应。
主要发现
- 氯胺酮可在治疗数小时至数天内捕捉从临床缓解到复发的行为变化,提供纵向机制研究的工具。
- 临床前 findings 支持突触连接及其脑网络效应在临床抑郁症病理与治疗中的作用。
临床怎么用
- 当前证据尚不足以支持氯胺酮以外的临床生物标志物或新疗法,临床应关注下游分子机制研究进展。
局限性
- 综述未报告临床生物标志物或氯胺酮以外新疗法的转化成果,受体靶点临床试验未成功。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The discovery of the rapid-acting antidepressant effects of ketamine has 1) led to a paradigm shift in our perception of what is possible in treating severe depression; 2) spurred a wave of basic, translation, and clinical research; and 3) provided an unprecedented investigational tool to conduct longitudinal mechanistic studies that may capture behavioral changes as complex as clinical remission and relapse within hours and days of treatment. Unfortunately, these advances did not yet translate into clinical biomarkers or novel treatments, beyond ketamine. In contrast to slow-acting antidepressants, in which targeting monoaminergic receptors identified several efficacious drugs with comparable mechanisms, the focus on the receptor targets of ketamine has failed in several clinical trials over the past decade. Thus, it is becoming increasingly crucial that we concentrate our effort on the downstream molecular mechanisms of ketamine and their effects on the brain circuitry and networks. Honoring the legacy of our mentor, friend, and colleague Ron Duman, we provide a historical note on the discovery of ketamine and its putative mechanisms. We then detail the molecular and circuits effect of ketamine based on preclinical findings, followed by a summary of the impact of this work on our understanding of chronic stress pathology across psychiatric disorders, with particular emphasis on the role of synaptic connectivity and its brain network effects in the pathology and treatment of clinical depression.
引用
- Shinohara R, Aghajanian GK, Abdallah CG, et al. Neurobiology of the Rapid-Acting Antidepressant Effects of Ketamine: Impact and Opportunities. Biol Psychiatry. 2020. PMID: 33568318. doi:10.1016/j.biopsych.2020.12.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。